These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8442088)

  • 1. Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone.
    D'Alessandro AM; Rankin M; McVey J; Hafez GR; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1207-9. PubMed ID: 8442088
    [No Abstract]   [Full Text] [Related]  

  • 2. RS-61443/cyclosporine combination therapy prolongs canine liver allograft survival.
    Bechstein WO; Schilling M; Steele DM; Hullett DA; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):702-3. PubMed ID: 8438445
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of canine intestinal allograft survival with RS-61443, cyclosporine, and prednisone.
    D'Alessandro AM; Rankin M; McVey J; Hafez GR; Sollinger HW; Kalayoglu M; Belzer FO
    Transplantation; 1993 Apr; 55(4):695-700; discussion 700-1. PubMed ID: 8475538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection.
    D'Alessandro AM; Rankin MA
    Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of a nonsteroid immunosuppressive regimen with RS-61443 and cyclosporine on kidney allograft survival in dogs.
    Papalois B; Wahoff D; Leone J; Aasheim T; Gilmore T; Sutherland DE
    Transplant Proc; 1996 Apr; 28(2):937. PubMed ID: 8623470
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs.
    Nakajima K; Ochiai T; Nagata M; Suzuki T; Gunji Y; Asano T; Shimada H; Isono K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):595-6. PubMed ID: 7679821
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
    Altaca G; Berber I; Aydin C; Yigit B; Aydin M; Titiz I
    Transplant Proc; 2001; 33(7-8):3248-9. PubMed ID: 11750391
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of pancreas allograft survival by mycophenolate mofetil in the rat.
    Qi S; Chen H; Xu D; Daloze P
    Transplant Proc; 1996 Apr; 28(2):932-3. PubMed ID: 8623468
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of basiliximab in pediatric renal transplantation.
    García-Meseguer C; Roldán M; Melgosa M; Alonso A; Peña A; Espìnosa L; Navarro M
    Transplant Proc; 2002 Feb; 34(1):102-3. PubMed ID: 11959206
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
    Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
    Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
    [No Abstract]   [Full Text] [Related]  

  • 11. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.
    Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A
    Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic effects of mycophenolate mofetil (MMF, RS-61443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats.
    Takazawa K; Hosoda Y; Bashuda H; Seino K; Yagita H; Tamatani T; Miyasaka M; Okumura K
    Transplant Proc; 1996 Jun; 28(3):1980-1. PubMed ID: 8658967
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
    Zhu Y; Suzuki T; Subbotin VM; Ishizaki N; Jin MB; Urakami A; Shimamura T; Starzl TE; Todo S
    Transplant Proc; 1997; 29(1-2):308-9. PubMed ID: 9123011
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of dog renal allograft survival by RS-61443, a new, potent immunosuppressive agent.
    Platz KP; Eckhoff DE; Hullett DA; Sollinger HW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):497-8. PubMed ID: 1990598
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
    Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
    [No Abstract]   [Full Text] [Related]  

  • 17. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
    Gannedahl G; Wanders A; Carlsson M; Tufveson G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.
    Morris RE; Wang J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):493-6. PubMed ID: 1990597
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
    Morris RE; Hoyt EG; Murphy MP; Eugui EM; Allison AC
    Transplant Proc; 1990 Aug; 22(4):1659-62. PubMed ID: 2389428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.